Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...